Your cart is currently empty!
Atazor R (Atazanavir+Ritonavir) Tablet
Generic brands for Atazanavir,Ritonavir Injection Available in India Brand Name Atazor R Generic Name Atazanavir+Ritonavir Strength Manufacturer Emcure Pharmaceuticals Ltd
Description
Description
This page contains brief details about the drug atazanavir,ritonavir, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Atazanavir, Ritonavir is an antiviral medication developed by the U.S. Food And Drug Administration for treating HIV-1 infection.
Mechanism of Action of Atazanavir,Ritonavir
Atazanavir, Ritonavir is indicated to treat HIV-1 infection. It is a Human immunodeficiency virus that mainly occurs when a person’s immune system is attacked and weakened by the human immunodeficiency virus (HIV). This infection progressively weakens the immune system, making individuals more susceptible to opportunistic infections.
Uses of Atazanavir,Ritonavir
Atazanavir, Ritonavir work together to inhibit the protease enzyme, which is necessary for the replication of HIV. By blocking this enzyme, this drug prevents the virus from multiplying and spreading in the body. It mainly helps reduce the viral load and slow the progression of HIV infection.
Atazanavir,Ritonavir Dosage available
It is an orally available prescription drug. Your doctor will decide the dose and duration of Atazanavir, Ritonavir based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, or crush the tablet. Swallow the whole tablet with water.
We can ship to :
News/Updates
References
- Cipla Ltd, US Food and Drug Administration, [ Revised on October 2017] [ Accessed on 18th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/206451PI.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 809 – 810.
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th Edition, 2011, Page: 1623-1660.